The two major research pathways that could change the future of people with multiple sclerosis, confirm themselves and a life where MS becomes a treatable and controllable condition comes a step closer.
A precise description of the clinical subtypes of multiple sclerosis is necessary in order to better classify each patient’s disease and better tailor their immunomodulatory therapy according to its course.
Why does a person with a particular predisposition due to hereditary genetic factors develop the disease at all? Lies Van Horebeek proposes a novel explanation in her research project...
In recent years, it has been shown that starting treatment early in MS patients significantly improves the long-term prognosis in the relapsing-remitting forms. It is therefore critically important that MS be diagnosed as soon as possible ...
The theme this year is 'Research'. In Belgium, the Belgian Charcot Foundation guarantees quality and continuity for more than 30 years with more than 200 researchers from the 23 recognized research centers.
